Blueair, a Sweden-based manufacturer of air purifiers, has been acquired by Unilever.
Bengt Rittri, found of Blueair, said, “We are saying yes to leveraging the help of Unilever, one of the world’s most admired corporations for its sustainability practices, to help Blueair take the next step to become a truly global provider of its health-enhancing air purifiers. Moving forward, Blueair will be geared to help potentially billions of people rather than millions to create safer, healthier indoor environments as air pollution rises worldwide.”
He added that he launched Blueair 20 years ago with the mission to start a clean air revolution by bringing consumers indoor air purifiers. “This mission remains embedded in Blueair today as we continuously work to elevate people’s health and wellbeing in a world where air pollution is now the world’s largest single environmental health risk,” said Rittri.
According to the company, Blueair will continue to operate under its existing brand name in all its markets, including the U.S., Sweden, China, Japan, South Korea and India.
In a separate statement, Unilever said that the air purification acquisition will further complement Unilever’s existing water purification business. Nitin Paranjpe, president of Unilever’s home care business, said, “We are delighted to be adding Blueair to our home care portfolio. The Blueair brand and products are widely known and represent exceptional quality and design, as well as superior capacity and performance. Blueair was founded on the belief that business should be a force for good in society, which is shared by Unilever.”
Unilever is one of the world’s leading suppliers of food, refreshment, home and personal care products with sales in over 190 countries and reaching two billion consumers a day, according to the company. Unilever has more than 400 brands found in homes, including Persil, Dove, Knorr, Domestos, Hellmann’s, Lipton, Wall’s, PG Tips, Ben & Jerry’s, Marmite, Magnum and Lynx.
Terms of the deal were not disclosed. The transaction is subject to customary regulatory approvals.